Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome

Angelo Maria Patti, Khalid Al-Rasadi, Niki Katsiki, Yajnavalka Banerjee, Dragana Nikolic, Luca Vanella, Rosaria Vincenza Giglio, Valeria Ausilia Giannone, Giuseppe Montalto, Manfredi Rizzo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The impact of a natural supplement (Kepar; Rikrea, Italy), containing several plant extracts such as curcuma longa, silymarin, guggul, chlorogenic acid, and inulin, was evaluated in 78 patients with metabolic syndrome (MetS; 45 men; age: 62 ± 9 years). Kepar at a dose of 2 pills/d was given for 4 months as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study. Anthropometric variables, plasma lipids, glucose parameters, and oxidative stress were measured at baseline and after 4 months. We found significant reductions in body weight (from 81.1 ± 13.5 to 79.4 ± 12.5 kg, P 2, P =.001), and waist circumference (from 105 ± 11 to 102 ± 10 cm, P =.0004) as well as in fasting glucose (from 6.5 [11.7] to 6.4 [7.6] mmol/L, P =.014) and total cholesterol (from 4.8 ± 1.4 to 4.5 ± 1.0 mmol/L, P =.03). No significant changes were found in the other appraised parameters, including oxidative stress. In conclusion, after few months of treatment Kepar seems to exert beneficial effects in patients with MetS. Larger studies with a longer follow-up period are needed to confirm these preliminary findings.

Original languageEnglish
Pages (from-to)856-861
Number of pages6
JournalAngiology
Volume66
Issue number9
DOIs
Publication statusPublished - Oct 9 2015

Fingerprint

Chlorogenic Acid
Curcuma
Oxidative Stress
Silymarin
Glucose
Inulin
Plant Extracts
Waist Circumference
Italy
Fasting
Therapeutics
Cholesterol
Body Weight
Lipids
Kepar

Keywords

  • chlorogenic acid
  • cholesterol
  • Curcuma longa
  • guggul
  • inulin
  • metabolic syndrome
  • natural supplement
  • oxidative stress
  • silymarin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome. / Patti, Angelo Maria; Al-Rasadi, Khalid; Katsiki, Niki; Banerjee, Yajnavalka; Nikolic, Dragana; Vanella, Luca; Giglio, Rosaria Vincenza; Giannone, Valeria Ausilia; Montalto, Giuseppe; Rizzo, Manfredi.

In: Angiology, Vol. 66, No. 9, 09.10.2015, p. 856-861.

Research output: Contribution to journalArticle

Patti, AM, Al-Rasadi, K, Katsiki, N, Banerjee, Y, Nikolic, D, Vanella, L, Giglio, RV, Giannone, VA, Montalto, G & Rizzo, M 2015, 'Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome', Angiology, vol. 66, no. 9, pp. 856-861. https://doi.org/10.1177/0003319714568792
Patti, Angelo Maria ; Al-Rasadi, Khalid ; Katsiki, Niki ; Banerjee, Yajnavalka ; Nikolic, Dragana ; Vanella, Luca ; Giglio, Rosaria Vincenza ; Giannone, Valeria Ausilia ; Montalto, Giuseppe ; Rizzo, Manfredi. / Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome. In: Angiology. 2015 ; Vol. 66, No. 9. pp. 856-861.
@article{25fed5bae428414bb8391e076c5b0ad6,
title = "Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome",
abstract = "The impact of a natural supplement (Kepar; Rikrea, Italy), containing several plant extracts such as curcuma longa, silymarin, guggul, chlorogenic acid, and inulin, was evaluated in 78 patients with metabolic syndrome (MetS; 45 men; age: 62 ± 9 years). Kepar at a dose of 2 pills/d was given for 4 months as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study. Anthropometric variables, plasma lipids, glucose parameters, and oxidative stress were measured at baseline and after 4 months. We found significant reductions in body weight (from 81.1 ± 13.5 to 79.4 ± 12.5 kg, P 2, P =.001), and waist circumference (from 105 ± 11 to 102 ± 10 cm, P =.0004) as well as in fasting glucose (from 6.5 [11.7] to 6.4 [7.6] mmol/L, P =.014) and total cholesterol (from 4.8 ± 1.4 to 4.5 ± 1.0 mmol/L, P =.03). No significant changes were found in the other appraised parameters, including oxidative stress. In conclusion, after few months of treatment Kepar seems to exert beneficial effects in patients with MetS. Larger studies with a longer follow-up period are needed to confirm these preliminary findings.",
keywords = "chlorogenic acid, cholesterol, Curcuma longa, guggul, inulin, metabolic syndrome, natural supplement, oxidative stress, silymarin",
author = "Patti, {Angelo Maria} and Khalid Al-Rasadi and Niki Katsiki and Yajnavalka Banerjee and Dragana Nikolic and Luca Vanella and Giglio, {Rosaria Vincenza} and Giannone, {Valeria Ausilia} and Giuseppe Montalto and Manfredi Rizzo",
year = "2015",
month = "10",
day = "9",
doi = "10.1177/0003319714568792",
language = "English",
volume = "66",
pages = "856--861",
journal = "Angiology",
issn = "0003-3197",
publisher = "SAGE Publications Inc.",
number = "9",

}

TY - JOUR

T1 - Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome

AU - Patti, Angelo Maria

AU - Al-Rasadi, Khalid

AU - Katsiki, Niki

AU - Banerjee, Yajnavalka

AU - Nikolic, Dragana

AU - Vanella, Luca

AU - Giglio, Rosaria Vincenza

AU - Giannone, Valeria Ausilia

AU - Montalto, Giuseppe

AU - Rizzo, Manfredi

PY - 2015/10/9

Y1 - 2015/10/9

N2 - The impact of a natural supplement (Kepar; Rikrea, Italy), containing several plant extracts such as curcuma longa, silymarin, guggul, chlorogenic acid, and inulin, was evaluated in 78 patients with metabolic syndrome (MetS; 45 men; age: 62 ± 9 years). Kepar at a dose of 2 pills/d was given for 4 months as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study. Anthropometric variables, plasma lipids, glucose parameters, and oxidative stress were measured at baseline and after 4 months. We found significant reductions in body weight (from 81.1 ± 13.5 to 79.4 ± 12.5 kg, P 2, P =.001), and waist circumference (from 105 ± 11 to 102 ± 10 cm, P =.0004) as well as in fasting glucose (from 6.5 [11.7] to 6.4 [7.6] mmol/L, P =.014) and total cholesterol (from 4.8 ± 1.4 to 4.5 ± 1.0 mmol/L, P =.03). No significant changes were found in the other appraised parameters, including oxidative stress. In conclusion, after few months of treatment Kepar seems to exert beneficial effects in patients with MetS. Larger studies with a longer follow-up period are needed to confirm these preliminary findings.

AB - The impact of a natural supplement (Kepar; Rikrea, Italy), containing several plant extracts such as curcuma longa, silymarin, guggul, chlorogenic acid, and inulin, was evaluated in 78 patients with metabolic syndrome (MetS; 45 men; age: 62 ± 9 years). Kepar at a dose of 2 pills/d was given for 4 months as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study. Anthropometric variables, plasma lipids, glucose parameters, and oxidative stress were measured at baseline and after 4 months. We found significant reductions in body weight (from 81.1 ± 13.5 to 79.4 ± 12.5 kg, P 2, P =.001), and waist circumference (from 105 ± 11 to 102 ± 10 cm, P =.0004) as well as in fasting glucose (from 6.5 [11.7] to 6.4 [7.6] mmol/L, P =.014) and total cholesterol (from 4.8 ± 1.4 to 4.5 ± 1.0 mmol/L, P =.03). No significant changes were found in the other appraised parameters, including oxidative stress. In conclusion, after few months of treatment Kepar seems to exert beneficial effects in patients with MetS. Larger studies with a longer follow-up period are needed to confirm these preliminary findings.

KW - chlorogenic acid

KW - cholesterol

KW - Curcuma longa

KW - guggul

KW - inulin

KW - metabolic syndrome

KW - natural supplement

KW - oxidative stress

KW - silymarin

UR - http://www.scopus.com/inward/record.url?scp=84941116306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941116306&partnerID=8YFLogxK

U2 - 10.1177/0003319714568792

DO - 10.1177/0003319714568792

M3 - Article

VL - 66

SP - 856

EP - 861

JO - Angiology

JF - Angiology

SN - 0003-3197

IS - 9

ER -